Synonyms | KBioGR_001078 AB00639940-08 L-Valsartan N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine ACT02671
MolPort-002-507-854 Prexxartan Aventis brand of valsartan N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine Sanol brand of valsartan BRD-K45158365-001-02-3 Spectrum2_001120 CGP-48933 (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid SW197658-2 D06UDG (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Valpression Esteve brand of valsartan 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard HMS2051L12 4997-EP2295422A2 Valtan I997 4997-EP2308562A2 KS-1194 AB07510 MCULE-6728882368 Nisis AKOS015914315 N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine PubChem9865 BCP05184 N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine SCHEMBL2542 C24H29N5O3 (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid Spectrum5_001582 CHEMBL1069 (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid TR-031794 Diovan (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine FT-0631156 Valsartan, >=98% (HPLC) HMS3651E04 4997-EP2298779A1 Valzaar (TN) Kalpress AB0013966 L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI) AC1L1U1M MLS000759423 NSC758927 AN-7255 N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE s1894 BIDD:GT0345 SPBio_001260 CEPA brand of valsartan (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid SR-05000001928-1 D00400 (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid VA11929 DS-1248 137862-53-4 Valsartan (JP17/USAN/INN) GTPL593 4997-EP2277879A1 Valsartan, United States Pharmacopeia (USP) Reference Standard HY-18204 4997-EP2301936A1 ZINC3875259 KBio2_007423 KBioSS_002289 AB00639940_09 Lacer brand of valsartan N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine ACWBQPMHZXGDFX-QFIPXVFZSA-N MolPort-003-666-608 Prexxartan (oral solution) AX8018200 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine SBI-0206738.P001 BRD-K45158365-001-05-6 Spectrum3_001831 CHEBI:9927 (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid Tareg (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Vals Exforge 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Valsartan [USAN:INN] HMS2093K22 4997-EP2298772A1 Valtan (TN) J-007068 4997-EP2308839A1 62V534 L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- AB2000354 MFCD00865840 Novartis brand of valsartan AKOS015994698 N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine RTR-031794 BDBM50049186 N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine Schwarz brand of valsartan CCG-101028 (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid Spectrum_001796 CPD000466318 (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid UNII-80M03YXJ7I Diovan (TN) (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine valsartan (Diovan) GP8514 4997-EP2270011A1 Valsartan, European Pharmacopoeia (EP) Reference Standard HMS3715P12 4997-EP2301923A1 Varexan KBio2_002287 AB00639940-06 L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- AC1Q5QIK MLS001424088 Pharmakon1600-01505209 ANW-49040 N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine SAM001246581 BR-58790 SPECTRUM1505209 CGP 48933 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid. ST2408288 D04HSR (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid VAL-489 EC 604-045-2 137863-60-6 Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard HMS1922L21 4997-EP2295406A1 Valsartan,(S) I14-41498 4997-EP2305219A1 [3H]valsartan KBio3_003006 KS-00000ISS AB00639940_11 LS-161334 NC00278 AK-58790 N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine Provas BC204156 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine SC-00971 BSPBio_003501 (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid Spectrum4_000749 (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid TL8000869 DB00177 (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine Valsarran EZR-104 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid Valsartan [USAN:USP:INN:BAN] HMS2232F05 4997-EP2298776A1 Valzaar J10013 80M03YXJ7I L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- AC-4543 Miten NSC-758927 AM90287 N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine S-6418 BG0645 SMR000466318 CCG-221275 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid SR-05000001928 CS-1967 (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid V-120 Diovan, Valsartan (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine Valsartan (JAN/USAN/INN) GTPL3937 4997-EP2272841A1 Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material HSDB 7519 4997-EP2301931A1 walsartan KBio2_004855 [ Show all ] |
---|
Inchi ID | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
---|